스포츠 의학용 혈액 기반 바이오마커 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 지역별, 경쟁별(2020-2030년)
Blood-based Biomarker For Sports Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Region & Competition, 2020-2030F
상품코드:1668158
리서치사:TechSci Research
발행일:2025년 02월
페이지 정보:영문 187 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
스포츠 의학용 혈액 기반 바이오마커 세계 시장은 2024년 7억 5,845만 달러로 평가되며, 예측 기간 동안 5.66%의 CAGR로 2030년에는 10억 5,772만 달러에 달할 것으로 예상됩니다.
의료 진단의 발전으로 개인화되고 정확한 운동선수 케어에 대한 수요가 증가함에 따라 스포츠 의학용 혈액 기반 바이오마커 시장은 전 세계적으로 빠르게 성장하고 있습니다. 혈액 기반 바이오마커는 운동선수의 생리적 상태, 부상 위험, 회복 진행 상황을 실시간으로 파악할 수 있다는 점에서 스포츠 의학 분야에서 각광받고 있습니다. 단백질, 대사산물, 유전자 마커를 포함한 이러한 바이오마커는 비침습적이고 객관적인 방법으로 운동선수의 운동능력과 건강의 다양한 측면을 모니터링할 수 있는 수단을 제공합니다. 시장 성장의 주요 촉진요인 중 하나는 스포츠 관련 부상 발생률의 증가입니다. 프로 및 아마추어 운동선수들이 최고의 기량을 발휘하기 위해 노력하면서 근육 긴장, 인대 파열, 뇌진탕과 같은 부상이 흔하게 발생하고 있습니다. 혈액 기반 바이오마커는 조직 손상, 염증, 스트레스와 관련된 상태를 조기에 발견하여 회복을 촉진하고 추가 합병증을 예방할 수 있도록 적시에 개입할 수 있게 해줍니다. 또한, 개인별 맞춤 스포츠 의학의 중요성이 강조되면서 개인별 생리적 반응에 기반한 맞춤형 훈련 및 재활 계획이 가능해져 바이오마커의 채택이 더욱 가속화되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
7억 5,845만 달러
시장 규모 : 2030년
10억 5,772만 달러
CAGR : 2025-2030년
5.66%
급성장 부문
크레아틴 키나아제(CK)
최대 시장
북미
바이오테크놀러지와 바이오마커 탐색의 발전도 시장을 발전시키고 있습니다. 크레아틴키나아제(CK), 젖산탈수소효소(LDH)와 같은 근육 손상 지표부터 C반응성 단백질(CRP), 인터류킨과 같은 산화 스트레스 및 염증 지표에 이르기까지 새로운 바이오마커에 대한 지속적인 연구로 측정 가능한 파라미터의 범위가 넓어지고 있습니다. 이러한 기술 혁신은 진단 정확도를 향상시킬 뿐만 아니라, 웨어러블 검사 기기 및 현장 검사 기기를 통해 실시간 모니터링을 용이하게함으로써 시장 수요를 더욱 촉진하고 있습니다.
주요 시장 촉진요인
스포츠 부상의 증가와 조기 발견의 필요성
주요 시장 동향
기술 발전
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 COVID-19가 세계의 스포츠 의학용 혈액 기반 바이오마커 시장에 미치는 영향
제5장 세계의 스포츠 의학용 혈액 기반 바이오마커 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
유형별(CK, 미오글로빈, 젖산, 백혈구수, 요소, CRP, 지질 및 단백질 하이드로퍼옥사이드, IL-6, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 스포츠 의학용 혈액 기반 바이오마커 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
멕시코
캐나다
제7장 유럽의 스포츠 의학용 혈액 기반 바이오마커 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
영국
이탈리아
스페인
제8장 아시아태평양의 스포츠 의학용 혈액 기반 바이오마커 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
인도
한국
일본
호주
제9장 남미의 스포츠 의학용 혈액 기반 바이오마커 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 스포츠 의학용 혈액 기반 바이오마커 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병(있는 경우)
제품 발매(있는 경우)
최근 동향
제13장 세계의 스포츠 의학용 혈액 기반 바이오마커 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Abbott Laboratories
BIOMERIEUX
F. Hoffmann-La Roche Ltd.
ARUP Laboratories Inc.
Siemens Healthineers AG
RayBiotech, Inc
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc
Beckman Coulter, Inc.
Randox Laboratories Ltd.
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
Global Blood-based Biomarker For Sports Medicine Market was valued at USD 758.45 Million in 2024 and is expected to reach USD 1057.72 Million by 2030 with a CAGR of 5.66% during the forecast period. The global blood-based biomarker market for sports medicine is experiencing rapid growth as advancements in medical diagnostics drive the demand for personalized and precise athlete care. Blood-based biomarkers have gained traction in the field of sports medicine due to their ability to provide real-time insights into an athlete's physiological status, injury risks, and recovery progress. These biomarkers, which include proteins, metabolites, and genetic markers, offer a non-invasive and objective means of monitoring various aspects of athletic performance and health. One of the primary drivers of market growth is the increasing incidence of sports-related injuries. As professional and amateur athletes strive for peak performance, injuries such as muscle strains, ligament tears, and concussions have become common. Blood-based biomarkers enable early detection of tissue damage, inflammation, and stress-related conditions, allowing for timely interventions that can enhance recovery and prevent further complications. Additionally, the growing emphasis on personalized sports medicine has fueled the adoption of these biomarkers, as they enable tailored training and rehabilitation plans based on an individual's unique physiological responses.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 758.45 Million
Market Size 2030
USD 1057.72 Million
CAGR 2025-2030
5.66%
Fastest Growing Segment
Creatine Kinase (CK)
Largest Market
North America
Advancements in biotechnology and biomarker discovery have also propelled the market forward. Continuous research into novel biomarkers has expanded the range of measurable parameters, from muscle damage indicators like creatine kinase (CK) and lactate dehydrogenase (LDH) to markers of oxidative stress and inflammation, such as C-reactive protein (CRP) and interleukins. These innovations are not only improving diagnostic accuracy but also facilitating real-time monitoring through wearable and point-of-care testing devices, further driving market demand.
Key Market Drivers
Rising Sports Injuries and Need for Early Detection
The increasing incidence of sports injuries across all levels of athletic participation is a major driver for the global blood-based biomarker for the sports medicine market. Athletes, both professional and amateur, are experiencing rising cases of muscle tears, ligament injuries, concussions, and stress fractures due to the growing intensity and competitiveness in sports. Traditional diagnostic methods, such as imaging techniques and physical assessments, often fail to detect early signs of damage, leading to delayed treatment and prolonged recovery periods. This has fueled the demand for blood-based biomarkers, which offer a minimally invasive and highly accurate means of detecting physiological and biochemical changes associated with sports-related injuries. According to the National Safety Council, in 2023, approximately 3.7 million individuals received emergency medical treatment for injuries related to sports and recreational equipment. The activities most commonly linked to these injuries include exercise, cycling, and basketball. One of the key advantages of blood-based biomarkers in sports medicine is their ability to provide early detection of injuries such as concussions and muscle damage. Biomarkers such as creatine kinase (CK), myoglobin, and C-reactive protein (CRP) can indicate muscle stress, inflammation, and tissue breakdown, allowing medical professionals to intervene before severe damage occurs. In addition, neuro biomarkers like S100 calcium-binding protein B (S100B) and tau protein are gaining attention for their role in detecting mild traumatic brain injuries (TBIs) in athletes, particularly in contact sports such as football, boxing, and rugby. The ability of these biomarkers to detect even subtle injuries has increased their adoption in sports medicine, as they facilitate personalized treatment plans and prevent long-term complications.
Key Market Trends
Technological Advancements
The blood-based biomarker for sports medicine market is witnessing significant growth, driven primarily by advancements in technology. These innovations are reshaping how biomarkers are detected, analyzed, and utilized in sports medicine to enhance athlete performance, injury prevention, and recovery monitoring. With the integration of cutting-edge diagnostic tools, artificial intelligence (AI), and wearable biosensors, the landscape of sports medicine is undergoing a transformation, making blood-based biomarkers more efficient and accessible. One of the major breakthroughs in this field is the development of high-sensitivity detection techniques, such as next-generation sequencing (NGS), mass spectrometry, and microfluidic platforms. These technologies have enhanced the precision of biomarker identification, allowing for early detection of muscle fatigue, inflammation, and potential injuries. NGS, for instance, enables comprehensive genomic and proteomic analysis from small blood samples, providing detailed insights into an athlete's physiological state. Similarly, mass spectrometry has improved the accuracy of biomarker quantification, leading to more reliable assessments of biochemical changes associated with sports-related stress and injuries.
Key Market Players
Abbott Laboratories
BIOMERIEUX
F. Hoffmann-La Roche Ltd.
ARUP Laboratories Inc.
Siemens Healthineers AG
RayBiotech, Inc
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc
Beckman Coulter, Inc.
Randox Laboratories Ltd.
Report Scope
In this report, the Global Blood-based Biomarker For Sports Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Blood-based Biomarker For Sports Medicine Market, By Type:
CK
Myoglobin
Lactate
WBC
Urea
CRP
Lipid and Protein Hydroperoxides
IL-6
Others
Blood-based Biomarker For Sports Medicine Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Blood-based Biomarker For Sports Medicine Market.
Available Customizations:
Global Blood-based Biomarker For Sports Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Blood-based Biomarker For Sports Medicine Market
5. Global Blood-based Biomarker For Sports Medicine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6, Others)
5.2.2. By Region
5.2.3. By Company (2024)
5.3. Market Map
6. North America Blood-based Biomarker For Sports Medicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Country
6.3. North America: Country Analysis
6.3.1. United States Blood-based Biomarker For Sports Medicine Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.2. Mexico Blood-based Biomarker For Sports Medicine Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.3. Canada Blood-based Biomarker For Sports Medicine Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By End Use
7. Europe Blood-based Biomarker For Sports Medicine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Country
7.3. Europe: Country Analysis
7.3.1. France Blood-based Biomarker For Sports Medicine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.2. Germany Blood-based Biomarker For Sports Medicine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.3. United Kingdom Blood-based Biomarker For Sports Medicine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.4. Italy Blood-based Biomarker For Sports Medicine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.5. Spain Blood-based Biomarker For Sports Medicine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
8. Asia Pacific Blood-based Biomarker For Sports Medicine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Blood-based Biomarker For Sports Medicine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.2. India Blood-based Biomarker For Sports Medicine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.3. South Korea Blood-based Biomarker For Sports Medicine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.4. Japan Blood-based Biomarker For Sports Medicine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.5. Australia Blood-based Biomarker For Sports Medicine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
9. South America Blood-based Biomarker For Sports Medicine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Blood-based Biomarker For Sports Medicine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.2. Argentina Blood-based Biomarker For Sports Medicine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.3. Colombia Blood-based Biomarker For Sports Medicine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
10. Middle East and Africa Blood-based Biomarker For Sports Medicine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Blood-based Biomarker For Sports Medicine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.2. Saudi Arabia Blood-based Biomarker For Sports Medicine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.3. UAE Blood-based Biomarker For Sports Medicine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Blood-based Biomarker For Sports Medicine Market: SWOT Analysis
